SREBF1 and metabolic dysfunction-associated steatotic liver disease: Accordingly, the present study demonstrated that MBC protects against NAFLD at least in part through increased AMPK phosphorylation and there by reduced SREBP-1c-mediated de novo lipogenesis and increased PPAR-α-dependent lipid oxidation.